UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of symptoms by gender and age in Japanese subjects with irritable bowel syndrome with constipation (IBS-C): a large population-based internet survey

BioPsychoSocial medicine, 2018-09, Vol.12 (1), p.12-12, Article 12

2018

Volltextzugriff (PDF)

Influence of the requirement for abdominal pain in the diagnosis of irritable bowel syndrome with constipation (IBS-C) under the Rome IV criteria using data from a large Japanese population-based internet survey

BioPsychoSocial medicine, 2018-12, Vol.12 (1), p.18-18, Article 18

2018

Volltextzugriff (PDF)

Effect of ramosetron in female patients with irritable bowel syndrome with diarrhea: a phase III long-term study

Journal of gastroenterology, 2016-09, Vol.51 (9), p.874-882

2016

Volltextzugriff (PDF)

Risk-Based Monitoring Approach to Ensure the Quality of Clinical Study Data and Enable Effective Monitoring

Therapeutic innovation & regulatory science, 2020, Vol.54 (1), p.139-143

2020

Volltextzugriff (PDF)

Ramosetron Reduces Symptoms of Irritable Bowel Syndrome With Diarrhea and Improves Quality of Life in Women

Gastroenterology (New York, N.Y. 1943), 2016-02, Vol.150 (2), p.358-366.e8

2016

Volltextzugriff (PDF)

Effect of Ramosetron on Stool Consistency in Male Patients With Irritable Bowel Syndrome With Diarrhea

Clinical gastroenterology and hepatology, 2014-06, Vol.12 (6), p.953-959.e4

2014

Volltextzugriff (PDF)

High‐dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double‐blind, placebo‐controlled study with a long‐term open‐label extension study in Japan

Neurogastroenterology and motility, 2019-01, Vol.31 (1), p.e13487-n/a

2019

Volltextzugriff (PDF)

Inactivation of a Novel Neuropeptide Y/Peptide YY Receptor Gene in Primate Species

The Journal of biological chemistry, 1996-11, Vol.271 (44), p.27217-27220

1996

Volltextzugriff (PDF)

A randomized controlled and long‐term linaclotide study of irritable bowel syndrome with constipation patients in Japan

Neurogastroenterology and motility, 2018-12, Vol.30 (12), p.e13444-n/a

2018

Volltextzugriff (PDF)

Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan

BioPsychoSocial medicine, 2016-06, Vol.10 (1), p.19-19, Article 19

2016

Volltextzugriff (PDF)

Dose‐finding study of linaclotide in Japanese patients with chronic constipation: A phase II randomized, double‐blind, and placebo‐controlled study

Neurogastroenterology and motility, 2018-12, Vol.30 (12), p.e13442-n/a

2018

Volltextzugriff (PDF)

Mo1627 Abdominal Bloating Is the Most Bothersome Symptom in Irritable Bowel Syndrome With Constipation (IBS-C): A Large Population-Based Internet Survey in Japan

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S735-S735

2016

Volltextzugriff (PDF)

Risk-Based Monitoring Approach to Ensure the Quality of Clinical Study Data and Enable Effective Monitoring

Therapeutic innovation & regulatory science, 2019-01, p.216847901881946

2019

Volltextzugriff (PDF)

Mo1281 Optimal Dose of Ramosetron in Female Patients With Irritable Bowel Syndrome With Diarrhea: A Randomized, Placebo-Controlled Phase II Trial

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-659-S-659

2015

Volltextzugriff (PDF)

315 Effect of Ramosetron in Female Patients With Irritable Bowel Syndrome With Diarrhea: A Randomized, Placebo-Controlled Phase III Trial

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-70-S-70

2015

Volltextzugriff (PDF)

Mo1280 Effect of Ramosetron in Female Patients With Irritable Bowel Syndrome With Diarrhea: Phase III Long-Term Study

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-659-S-659

2015

Volltextzugriff (PDF)

Mo1626 Determining an Optimal Dose of Linaclotide in Use in Japanese Patients With Irritable Bowel Syndrome With Constipation: A Phase II Randomized, Double-Blind, Placebo-Controlled Study

Gastroenterology (New York, N.Y. 1943), 2016-04, Vol.150 (4), p.S735-S735

2016

Volltextzugriff (PDF)

Cover Image

Neurogastroenterology and motility, 2019-01, Vol.31 (1)

2019

Volltextzugriff (PDF)

Dose-Finding of Linaclotide for Patients with Chronic Constipation in Japan: A Phase II Randomized, Double-Blind, and Placebo-Controlled Study

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S515-S516

2017

Volltextzugriff (PDF)

Mo1548 - Linaclotide is Effective and Safe for Patients with Irritable Bowel Syndrome with Constipation in Japan: A Phase III Randomized, Double-Blind, and Placebo-Controlled and Long-Term Extension Study

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S714-S714

2017

Volltextzugriff (PDF)

Linaclotide is Effective and Safe for Patients with Irritable Bowel Syndrome with Constipation in Japan: A Phase III Randomized, Double-Blind, and Placebo-Controlled and Long-Term Extension Study

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S714-S714

2017

Volltextzugriff (PDF)

Su1543 - Dose-Finding of Linaclotide for Patients with Chronic Constipation in Japan: A Phase II Randomized, Double-Blind, and Placebo-Controlled Study

Gastroenterology (New York, N.Y. 1943), 2017-04, Vol.152 (5), p.S515-S516

2017

Volltextzugriff (PDF)

Risk-Based Monitoring Approach to Ensure the Quality of Clinical Study Data and Enable Effective Monitoring

Therapeutic innovation & regulatory science, 2019-01, p.2168479018819464

2019

Volltextzugriff (PDF)

Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea

BioPsychoSocial medicine, 2017-03, Vol.11 (1), p.8-8, Article 8

2017

Volltextzugriff (PDF)

A Long-Term Study of Acotiamide in Patients With Functional Dyspepsia : Results From an Open-Labeled Phase III Trial in Japan on Safety and Efficacy

Gastroenterology (New York, N.Y. 1943), 2011, Vol.140 (5), p.S-805-S-805

2011

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(38)

Sprache

Englisch
(35)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(17)
Science & Technology
(17)
Gastroenterology And Hepatology
(10)
Animals
(8)
Humans
(7)
Irritable Bowel Syndrome
(7)
Neurosciences
(7)
Neurosciences & Neurology
(7)
Abdominal Pain
(6)
Constipation
(6)
Gastroenterology & Hepatology
(6)
Intestine
(6)
Diarrhea
(5)
Male
(5)
Adult
(4)
Benzimidazoles - Therapeutic Use
(4)
Diarrhea - Drug Therapy
(4)
Female
(4)
Gastroenterology
(4)
Irritable Bowel Syndrome - Drug Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of symptoms by gender and age in Japanese subjects with irritable bowel syndrome with constipation (IBS-C): a large population-based internet survey

Influence of the requirement for abdominal pain in the diagnosis of irritable bowel syndrome with constipation (IBS-C) under the Rome IV criteria using data from a large Japanese population-based internet survey

Effect of ramosetron in female patients with irritable bowel syndrome with diarrhea: a phase III long-term study

Risk-Based Monitoring Approach to Ensure the Quality of Clinical Study Data and Enable Effective Monitoring

Ramosetron Reduces Symptoms of Irritable Bowel Syndrome With Diarrhea and Improves Quality of Life in Women

Effect of Ramosetron on Stool Consistency in Male Patients With Irritable Bowel Syndrome With Diarrhea

High‐dose linaclotide is effective and safe in patients with chronic constipation: A phase III randomized, double‐blind, placebo‐controlled study with a long‐term open‐label extension study in Japan

Inactivation of a Novel Neuropeptide Y/Peptide YY Receptor Gene in Primate Species

A randomized controlled and long‐term linaclotide study of irritable bowel syndrome with constipation patients in Japan

Abdominal bloating is the most bothersome symptom in irritable bowel syndrome with constipation (IBS-C): a large population-based Internet survey in Japan

Dose‐finding study of linaclotide in Japanese patients with chronic constipation: A phase II randomized, double‐blind, and placebo‐controlled study

Mo1627 Abdominal Bloating Is the Most Bothersome Symptom in Irritable Bowel Syndrome With Constipation (IBS-C): A Large Population-Based Internet Survey in Japan

Risk-Based Monitoring Approach to Ensure the Quality of Clinical Study Data and Enable Effective Monitoring

Mo1281 Optimal Dose of Ramosetron in Female Patients With Irritable Bowel Syndrome With Diarrhea: A Randomized, Placebo-Controlled Phase II Trial

315 Effect of Ramosetron in Female Patients With Irritable Bowel Syndrome With Diarrhea: A Randomized, Placebo-Controlled Phase III Trial

Mo1280 Effect of Ramosetron in Female Patients With Irritable Bowel Syndrome With Diarrhea: Phase III Long-Term Study

Mo1626 Determining an Optimal Dose of Linaclotide in Use in Japanese Patients With Irritable Bowel Syndrome With Constipation: A Phase II Randomized, Double-Blind, Placebo-Controlled Study

Cover Image

Dose-Finding of Linaclotide for Patients with Chronic Constipation in Japan: A Phase II Randomized, Double-Blind, and Placebo-Controlled Study

Mo1548 - Linaclotide is Effective and Safe for Patients with Irritable Bowel Syndrome with Constipation in Japan: A Phase III Randomized, Double-Blind, and Placebo-Controlled and Long-Term Extension Study

Linaclotide is Effective and Safe for Patients with Irritable Bowel Syndrome with Constipation in Japan: A Phase III Randomized, Double-Blind, and Placebo-Controlled and Long-Term Extension Study

Su1543 - Dose-Finding of Linaclotide for Patients with Chronic Constipation in Japan: A Phase II Randomized, Double-Blind, and Placebo-Controlled Study

Risk-Based Monitoring Approach to Ensure the Quality of Clinical Study Data and Enable Effective Monitoring

Randomized, placebo-controlled, phase IV pilot study of ramosetron to evaluate the co-primary end points in male patients with irritable bowel syndrome with diarrhea

A Long-Term Study of Acotiamide in Patients With Functional Dyspepsia : Results From an Open-Labeled Phase III Trial in Japan on Safety and Efficacy

Suchergebnisse filtern